DERIVADOS DE DIACIL-HIDRAZINA
Diacylhydrazine derivatives of general formula (I)wherein X, Y, Z, R , and R are as defined herein, and their physiologically acceptable salts or solvates thereof, are integrin inhibitors and can be used to combat thromboses, myocardial infarcts, coronary cardiac diseases, arteriosclerosis, inflamma...
Gespeichert in:
| Hauptverfasser: | , , , , |
|---|---|
| Format: | Patent |
| Sprache: | por |
| Schlagworte: | |
| Online-Zugang: | Volltext bestellen |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | |
|---|---|
| container_issue | |
| container_start_page | |
| container_title | |
| container_volume | |
| creator | SIMON GOODMAN GUNTER HOLZEMANN GABOR SULYOK CHRISTOPH GIBSON HORST KESSLER, -DR |
| description | Diacylhydrazine derivatives of general formula (I)wherein X, Y, Z, R , and R are as defined herein, and their physiologically acceptable salts or solvates thereof, are integrin inhibitors and can be used to combat thromboses, myocardial infarcts, coronary cardiac diseases, arteriosclerosis, inflammations, tumors, osteoporosis, infections, and restenosis following angioplasty or during pathological processes that are maintained or propagated by angiogenesis. |
| format | Patent |
| fullrecord | <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_PT1194401EE</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>PT1194401EE</sourcerecordid><originalsourceid>FETCH-epo_espacenet_PT1194401EE3</originalsourceid><addsrcrecordid>eNrjZJB1cQ3yDHN08Q9WcHFVcPF0dPb00fXwdAlyjPL0c-RhYE1LzClO5YXS3AwKbq4hzh66qQX58anFBYnJqXmpJfEBIYaGliYmBoaursZEKAEARGgguQ</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>DERIVADOS DE DIACIL-HIDRAZINA</title><source>esp@cenet</source><creator>SIMON GOODMAN ; GUNTER HOLZEMANN ; GABOR SULYOK ; CHRISTOPH GIBSON ; HORST KESSLER, -DR</creator><creatorcontrib>SIMON GOODMAN ; GUNTER HOLZEMANN ; GABOR SULYOK ; CHRISTOPH GIBSON ; HORST KESSLER, -DR</creatorcontrib><description>Diacylhydrazine derivatives of general formula (I)wherein X, Y, Z, R , and R are as defined herein, and their physiologically acceptable salts or solvates thereof, are integrin inhibitors and can be used to combat thromboses, myocardial infarcts, coronary cardiac diseases, arteriosclerosis, inflammations, tumors, osteoporosis, infections, and restenosis following angioplasty or during pathological processes that are maintained or propagated by angiogenesis.</description><edition>7</edition><language>por</language><subject>ACYCLIC OR CARBOCYCLIC COMPOUNDS ; CHEMISTRY ; HETEROCYCLIC COMPOUNDS ; HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; METALLURGY ; ORGANIC CHEMISTRY ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES ; SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><creationdate>2004</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20040227&DB=EPODOC&CC=PT&NR=1194401E$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,776,881,25542,76290</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20040227&DB=EPODOC&CC=PT&NR=1194401E$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>SIMON GOODMAN</creatorcontrib><creatorcontrib>GUNTER HOLZEMANN</creatorcontrib><creatorcontrib>GABOR SULYOK</creatorcontrib><creatorcontrib>CHRISTOPH GIBSON</creatorcontrib><creatorcontrib>HORST KESSLER, -DR</creatorcontrib><title>DERIVADOS DE DIACIL-HIDRAZINA</title><description>Diacylhydrazine derivatives of general formula (I)wherein X, Y, Z, R , and R are as defined herein, and their physiologically acceptable salts or solvates thereof, are integrin inhibitors and can be used to combat thromboses, myocardial infarcts, coronary cardiac diseases, arteriosclerosis, inflammations, tumors, osteoporosis, infections, and restenosis following angioplasty or during pathological processes that are maintained or propagated by angiogenesis.</description><subject>ACYCLIC OR CARBOCYCLIC COMPOUNDS</subject><subject>CHEMISTRY</subject><subject>HETEROCYCLIC COMPOUNDS</subject><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>METALLURGY</subject><subject>ORGANIC CHEMISTRY</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><subject>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2004</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNrjZJB1cQ3yDHN08Q9WcHFVcPF0dPb00fXwdAlyjPL0c-RhYE1LzClO5YXS3AwKbq4hzh66qQX58anFBYnJqXmpJfEBIYaGliYmBoaursZEKAEARGgguQ</recordid><startdate>20040227</startdate><enddate>20040227</enddate><creator>SIMON GOODMAN</creator><creator>GUNTER HOLZEMANN</creator><creator>GABOR SULYOK</creator><creator>CHRISTOPH GIBSON</creator><creator>HORST KESSLER, -DR</creator><scope>EVB</scope></search><sort><creationdate>20040227</creationdate><title>DERIVADOS DE DIACIL-HIDRAZINA</title><author>SIMON GOODMAN ; GUNTER HOLZEMANN ; GABOR SULYOK ; CHRISTOPH GIBSON ; HORST KESSLER, -DR</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_PT1194401EE3</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>por</language><creationdate>2004</creationdate><topic>ACYCLIC OR CARBOCYCLIC COMPOUNDS</topic><topic>CHEMISTRY</topic><topic>HETEROCYCLIC COMPOUNDS</topic><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>METALLURGY</topic><topic>ORGANIC CHEMISTRY</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><topic>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</topic><toplevel>online_resources</toplevel><creatorcontrib>SIMON GOODMAN</creatorcontrib><creatorcontrib>GUNTER HOLZEMANN</creatorcontrib><creatorcontrib>GABOR SULYOK</creatorcontrib><creatorcontrib>CHRISTOPH GIBSON</creatorcontrib><creatorcontrib>HORST KESSLER, -DR</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>SIMON GOODMAN</au><au>GUNTER HOLZEMANN</au><au>GABOR SULYOK</au><au>CHRISTOPH GIBSON</au><au>HORST KESSLER, -DR</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>DERIVADOS DE DIACIL-HIDRAZINA</title><date>2004-02-27</date><risdate>2004</risdate><abstract>Diacylhydrazine derivatives of general formula (I)wherein X, Y, Z, R , and R are as defined herein, and their physiologically acceptable salts or solvates thereof, are integrin inhibitors and can be used to combat thromboses, myocardial infarcts, coronary cardiac diseases, arteriosclerosis, inflammations, tumors, osteoporosis, infections, and restenosis following angioplasty or during pathological processes that are maintained or propagated by angiogenesis.</abstract><edition>7</edition><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext_linktorsrc |
| identifier | |
| ispartof | |
| issn | |
| language | por |
| recordid | cdi_epo_espacenet_PT1194401EE |
| source | esp@cenet |
| subjects | ACYCLIC OR CARBOCYCLIC COMPOUNDS CHEMISTRY HETEROCYCLIC COMPOUNDS HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE METALLURGY ORGANIC CHEMISTRY PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS |
| title | DERIVADOS DE DIACIL-HIDRAZINA |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-04T02%3A41%3A22IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=SIMON%20GOODMAN&rft.date=2004-02-27&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EPT1194401EE%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true |